Perspective
Accepted on 18 Jul 2025
Clinicians' View on Non-adherence: Sharing Expert Opinion
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1636806
Type at least 3 characters
2,111 articles
Original Research
Accepted on 18 Jul 2025
Safety and effectiveness of apixaban use for stroke prevention during Ramadan fasting (The API-Ram Study)
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1565094
Original Research
Accepted on 18 Jul 2025
PPI in preventing gastrointestinal injury in minor ischemic stroke or TIA patients at low risk of gastrointestinal bleeding treated with short-term dual antiplatelet therapy
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1644148
Original Research
Published on 18 Jul 2025
Efficacy and safety of telitacicept in systemic lupus erythematosus with lupus nephritis and nephrotic syndrome: a 12-month retrospective cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613790
- 356 views
Original Research
Published on 17 Jul 2025
Shaping national rare diseases definition in Saudi Arabia: outcome from health ecosystem multisectoral workshop
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1595967
- 498 views
Original Research
Accepted on 16 Jul 2025
Association of early acetaminophen administration with mortality in surgical intensive care patients: a retrospective cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588978
Original Research
Published on 16 Jul 2025
Pakistan’s first medicine price deregulation policy: assessing its impact on prices, affordability, and availability of oral anti-diabetic medicines in private pharmacies
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1627735
- 583 views
Review
Published on 16 Jul 2025
A scoping review about smoking, smoking cessation and their effects on anti-tuberculosis agents: insights into drug metabolisms, safety, and effectiveness
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1606150
- 397 views
Policy and Practice Reviews
Accepted on 15 Jul 2025
Comprehensive Promotion of Drug Traceability Codes in China in 2025: Challenges and Solutions for Tertiary Outpatient Pharmacists
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1619916
- 154 views
Original Research
Accepted on 15 Jul 2025
Aspirin is associated with a reduction in mortality rate for patients with sepsis-induced coagulopathy: A retrospective cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1537994
Original Research
Accepted on 15 Jul 2025
Geographical and temporal variations in availability of national price negotiated novel anticancer drugs: a spatial statistical study based on two cross-sectional datasets in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1604008
Original Research
Accepted on 15 Jul 2025
Early Acetaminophen Use and 90-Day Mortality in ICU Patients with Ischemic Stroke
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1622440
Systematic Review
Published on 15 Jul 2025
Low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis jirovecii pneumonia in HIV-uninfected patients: a systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545436
- 355 views
Systematic Review
Published on 14 Jul 2025
Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients with liver disease: a systematic review and meta-analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620394
- 394 views
Methods
Published on 11 Jul 2025
Effectiveness of a structured pharmaceutical review of pharmacotherapeutic plans to reduce drug-related problems in nursing homes: a study protocol of a pragmatic quasi-experimental trial
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1522650
- 488 views
Original Research
Accepted on 09 Jul 2025
Comparative Cardiovascular Outcomes of Aripiprazole vs. Risperidone in Patients with Type 2 Diabetes and Schizophrenia: A Retrospective Cohort Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1617534
- 156 views